Edurne Novella-Maestre

No ORCID on file · 16 papers in corpus
rct 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.06.020

RESEARCH QUESTION: Does 3-months of gonadotrophin releasing hormone agonist (GnRHa) treatment before IVF improve clinical pregnancy rate in infertile patients with endometriosis? DESIGN: Single-blind, placebo-controlled clinical trial of 2…

lab-animal 2016

Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis

other 2016
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-016-0161-1

BACKGROUND: During cytoplasmic oocyte maturation, Ca(2+) currents are vital for regulating a broad range of physiological processes. Recent studies have demonstrated that DMSO and EG cause large transient increases in intracellular Ca(2+) i…

lab-animal 2012
Fertility and sterility ·doi:10.1016/j.fertnstert.2012.07.1103

OBJECTIVE: To investigate the effect of antiangiogenic treatment on experimental endometriotic lesion nerve fibers. DESIGN: Heterologous mouse model of endometriosis. SETTING: University Institute IVI, University Hospital La Fe. ANIMAL(S…

2012
·doi:10.1093/humrep/27.s2.72
review 2011
·doi:10.1017/cbo9780511734755.011

This chapter addresses the controversies surrounding the impact and surgical management of hydrosalpinges and uterine leiomyoma on in vitro fertilization (IVF) cycle outcome. Evidence accumulated over the last 15 years suggests that either …

review 2011
·doi:10.1017/cbo9780511734755

Human Assisted Reproductive Technology: Future Trends in Laboratory and Clinical Practice offers a collection of concise, practical review articles on cutting-edge topics within reproductive medicine. Each article presents a balanced view o…

2011
·doi:10.1093/humrep/26.s1.80
2010
·doi:10.5005/jp/books/11032_31
other 2010
Biology of reproduction ·doi:10.1095/biolreprod.110.084392

Previous studies in an experimental mouse model of endometriosis have shown that the dopamine agonist (DA) cabergoline (Cb2) reduces angiogenesis and endometriotic lesions, hypothetically binding to the dopamine receptor type-2 (DRD2). To d…

other 2010

The use of a dopamine agonist in the manufacture of a medicament for the treatment or prevention of endometriosis.

2010
·doi:10.1093/humrep/deq066
lab-animal 2009
Human Reproduction ·doi:10.1093/humrep/den499

BACKGROUND: Implantation of a retrogradely-shed endometrium during menstruation requires an adequate blood supply. The endometrium has angiogenic potential, and endometriotic lesions grow in areas with a rich vascularization, suggesting tha…

lab-animal 2009
·doi:10.1097/01.ogx.0000359267.83853.0f

Survival of newly implanted retrograde–shed endometrial tissue during menstruation in an ectopic location requires an adequate blood supply. This suggests that angiogenesis is a prerequisite for the development of endometriosis and that its…

2007
·doi:10.1016/j.fertnstert.2007.07.141
lab-animal 2007
·doi:10.1093/humrep/dem1030

also sensitized ESC to Fas-mediated apoptosis, but this effect seems not to be mediated by the downregulation of FLIP, an inhibitor of caspase-8 activation. Conclusion: In summary, we demonstrate that human ESC are primarily resistant to ap…